FDA grants priority review to Pfizer/BioNTech Covid-19 vaccine; decision on approval expected by January 2022
Pfizer and BioNTech announced Friday that the US Food and Drug Administration has granted priority review designation to the companies' application for approval of their Covid-19 v…